{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:47:44Z","timestamp":1771606064380,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11886-022-01761-x","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:02:58Z","timestamp":1660820578000},"page":"1417-1424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transcatheter Mitral Valve Replacement in Failed Bioprosthetic Surgical Valves and Surgical Annuloplasty Rings"],"prefix":"10.1007","volume":"24","author":[{"given":"Marvin H.","family":"Eng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr E.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"1761_CR1","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jtcvs.2014.02.050","volume":"148","author":"T Bourguignon","year":"2014","unstructured":"Bourguignon T, Bouquiaux-Stablo AL, Loardi C, et al. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148:2004-2011.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1761_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2013.04.030","volume":"62","author":"L Mauri","year":"2013","unstructured":"Mauri L, Foster E, Glower DD, et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"1761_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1312808","volume":"370","author":"MA Acker","year":"2014","unstructured":"Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23\u201332.","journal-title":"N Engl J Med"},{"key":"1761_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.athoracsur.2008.09.030","volume":"87","author":"M Maganti","year":"2009","unstructured":"Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87:521\u20135.","journal-title":"Ann Thorac Surg"},{"key":"1761_CR5","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1161\/CIR.0000000000000029","volume":"129","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines. Circulation. 2014;129:2440\u201392.","journal-title":"Circulation"},{"key":"1761_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jacc.2017.07.714","volume":"70","author":"S-H Yoon","year":"2017","unstructured":"\u2022\u2022 Yoon S-H, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol. 2017;70:1121\u201331. (Retrospective study describing the outcomes of MViV and MViR procedures across a multicenter registry.)","journal-title":"J Am Coll Cardiol"},{"key":"1761_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamacardio.2020.2974","volume":"5","author":"B Whisenant","year":"2020","unstructured":"\u2022\u2022 Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol. 2020;5:1245\u201352. (Large study detailing the outcomes of MViV using the Edwards Sapien 3 prosthesis and its relative safety. This is the first study to associate small mitral THV with increased mortality.)","journal-title":"JAMA Cardiol"},{"key":"1761_CR8","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/ejcts\/ezv384","volume":"49","author":"T Bourguignon","year":"2016","unstructured":"Bourguignon T, Lhommet P, El Khoury R, et al. Very long-term outcomes of the Carpentier-Edwards perimount aortic valve in patients aged 50\u201365 years. Eur J Cardiothorac Surg. 2016;49:1462\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1761_CR9","doi-asserted-by":"crossref","unstructured":"\u2022 Bapat V. Valve-in-valve apps: why and how they were developed and how to use them. EuroIntervention 2014;10 Suppl U:U44\u201351. (This manuscript describes the mitral valve-in-valve application uses and limitations.)","DOI":"10.4244\/EIJV10SUA7"},{"key":"1761_CR10","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jacc.2013.01.058","volume":"61","author":"A Cheung","year":"2013","unstructured":"Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1761_CR11","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","volume":"131","author":"EH Blackstone","year":"2015","unstructured":"Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015;131:1989\u20132000.","journal-title":"Circulation"},{"key":"1761_CR12","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.athoracsur.2015.01.029","volume":"99","author":"HB Ribeiro","year":"2015","unstructured":"Ribeiro HB, Dahou A, Urena M, et al. Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement. Ann Thorac Surg. 2015;99:2001\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1761_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jacc.2013.11.046","volume":"63","author":"T Tanawuttiwat","year":"2014","unstructured":"Tanawuttiwat T, O\u2019Neill BP, Cohen MG, et al. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches. J Am Coll Cardiol. 2014;63:1510\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1761_CR14","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jcin.2017.06.069","volume":"10","author":"M Urena","year":"2017","unstructured":"Urena M, Himbert D, Brochet E, et al. Transseptal transcatheter mitral valve replacement using balloon-expandable transcatheter heart valves: a step-by-step approach. JACC Cardiovasc Interv. 2017;10:1905\u201319.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurheartj\/ehy590","volume":"40","author":"SH Yoon","year":"2019","unstructured":"\u2022\u2022 Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441\u201351. (This is an updated dataset for the multicenter registry detailing the attenuated outcomes of MViR and valve-in-MAC procedures. It reaffirms the superior safety and efficacy of MViV procedures.)","journal-title":"Eur Heart J"},{"key":"1761_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcmg.2016.01.005","volume":"10","author":"P Blanke","year":"2017","unstructured":"Blanke P, Naoum C, Dvir D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the Neo-LVOT. JACC Cardiovasc Imaging. 2017;10:482\u20135.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1761_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jcin.2018.12.001","volume":"12","author":"SH Yoon","year":"2019","unstructured":"\u2022\u2022 Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2019;12:182\u201393. (Using the international, multi-center data repository, this study identifies the inflection point for neo-LVOT area and outflow tract obstruction with TMVR. This dataset illustrates the morbidity and mortality associated with LVOTO.)","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR18","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jcmg.2016.01.017","volume":"11","author":"DD Wang","year":"2016","unstructured":"\u2022 Wang DD, Eng MH, Greenbaum A, et al. Predicting left ventricular outflow tract obstruction after transcatheter mitral valve replacement (TMVR): initial single center experience. JACC Cardiovasc Imaging. 2016;11:1349\u201352. (The first manuscript identifying a neo-LVOT area inflection point for obstruction.)","journal-title":"JACC Cardiovasc Imaging"},{"key":"1761_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ehjci\/jeab074","volume":"23","author":"K Kohli","year":"2022","unstructured":"Kohli K, Wei ZA, Sadri V, et al. Dynamic nature of the LVOT following transcatheter mitral valve replacement with LAMPOON: new insights from post-procedure imaging. Eur Heart J Cardiovasc Imaging. 2022;23:650\u201362.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1761_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ccd.27054","volume":"92","author":"AB Greenbaum","year":"2018","unstructured":"Greenbaum AB, Condado JF, Eng M, et al. Long or redundant leaflet complicating transcatheter mitral valve replacement: case vignettes that advocate for removal or reduction of the anterior mitral leaflet. Catheter Cardiovasc Interv. 2018;92:627\u201332.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1761_CR21","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.jcin.2020.07.024","volume":"13","author":"AB Greenbaum","year":"2020","unstructured":"Greenbaum AB, Lisko JC, Gleason PT, et al. Annular-to-apical \u201cemory angle\u201d to ensure coaxial mitral implantation of the SAPIEN 3 valve. JACC Cardiovasc Interv. 2020;13:2447\u201350.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR22","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.jacc.2019.02.076","volume":"73","author":"JM Khan","year":"2019","unstructured":"Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73:2521\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"1761_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008903","volume":"13","author":"JC Lisko","year":"2020","unstructured":"Lisko JC, Greenbaum AB, Khan JM, et al. Antegrade intentional laceration of the anterior mitral leaflet to prevent left ventricular outflow tract obstruction. Circ Cardiovasc Interv. 2020;13: e008903.","journal-title":"Circ Cardiovasc Interv"},{"key":"1761_CR24","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/ccd.26975","volume":"90","author":"M Guerrero","year":"2017","unstructured":"Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv. 2017;90:1220\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1761_CR25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jcin.2020.02.016","volume":"13","author":"ME Guerrero","year":"2020","unstructured":"Guerrero ME, Killu AM, Gonzalez-Quesada C, et al. Pre-emptive radiofrequency septal ablation to decrease the risk of left ventricular outflow tract obstruction after TMVR. JACC Cardiovasc Interv. 2020;13:1129\u201332.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR26","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jcin.2019.02.034","volume":"12","author":"DD Wang","year":"2019","unstructured":"Wang DD, Guerrero M, Eng MH, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC Cardiovasc Interv. 2019;12:1268\u201379.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR27","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.jcin.2021.08.044","volume":"14","author":"VC Babaliaros","year":"2021","unstructured":"Babaliaros VC, Lederman RJ, Gleason PT, et al. The art of SAPIEN 3 transcatheter mitral valve replacement in valve-in-ring and valve-in-mitral-annular-calcification procedures. JACC Cardiovasc Interv. 2021;14:2195\u2013214.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR28","doi-asserted-by":"crossref","unstructured":"Khan JM, Bruce CG, Greenbaum AB et al. Transcatheter myotomy to relieve left ventricular outflow tract obstruction: the septal scoring along the midline endocardium procedure in animals. Circ Cardiovasc Interv 2022:101161circinterventions121011686.","DOI":"10.1161\/CIRCINTERVENTIONS.121.011686"},{"key":"1761_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ccd.28731","volume":"96","author":"MH Eng","year":"2020","unstructured":"Eng MH, Kherallah RY, Guerrero M, et al. Complete percutaneous apical access and closure: short and intermediate term outcomes. Catheter Cardiovasc Interv. 2020;96:481\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1761_CR30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/ccd.29783","volume":"98","author":"MH Eng","year":"2021","unstructured":"Eng MH, Kargoli F, Wang DD, et al. Short- and mid-term outcomes in percutaneous mitral valve replacement using balloon expandable valves. Catheter Cardiovasc Interv. 2021;98:1193\u2013203.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1761_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jcin.2011.05.018","volume":"4","author":"V Jelnin","year":"2011","unstructured":"Jelnin V, Dudiy Y, Einhorn BN, Kronzon I, Cohen HA, Ruiz CE. Clinical experience with percutaneous left ventricular transapical access for interventions in structural heart defects a safe access and secure exit. JACC Cardiovasc Interv. 2011;4:868\u201374.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR32","doi-asserted-by":"publisher","first-page":"E150","DOI":"10.1002\/ccd.25076","volume":"83","author":"VV Bapat","year":"2014","unstructured":"Bapat VV, Khaliel F, Ihleberg L. Delayed migration of Sapien valve following a transcatheter mitral valve-in-valve implantation. Catheter Cardiovasc Interv. 2014;83:E150\u20134.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1761_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCULATIONAHA.120.049088","volume":"143","author":"M Simonato","year":"2021","unstructured":"Simonato M, Whisenant B, Ribeiro HB, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive midterm evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation. 2021;143:104\u201316.","journal-title":"Circulation"},{"key":"1761_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jcin.2020.01.235","volume":"13","author":"BC Case","year":"2020","unstructured":"Case BC, Khan JM, Satler LF, et al. Tip-to-base LAMPOON to prevent left ventricular outflow tract obstruction in valve-in-valve transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2020;13:1126\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jcin.2021.01.016","volume":"14","author":"AB Greenbaum","year":"2021","unstructured":"Greenbaum AB, Perdoncin E, Paone G, et al. Tableside skirt modification of the SAPIEN 3 valve to reduce paravalvular leak during transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2021;14:932\u20134.","journal-title":"JACC Cardiovasc Interv"},{"key":"1761_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008425","volume":"13","author":"M Guerrero","year":"2020","unstructured":"\u2022\u2022 Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the United States. Circ Cardiovasc Interv. 2020;13: e008425. (Using the National Transcatheter Valve Therapeutics, this manuscript describes the contemporary outcomes for MViV, MViR and valve-in-MAC outcomes out to 30 days.)","journal-title":"Circ Cardiovasc Interv"},{"key":"1761_CR37","unstructured":"Otto CM, Nishimura RA, Bonow RO et al. 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2020:CIR0000000000000923."},{"key":"1761_CR38","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jtcvs.2006.12.071","volume":"133","author":"BK Lam","year":"2007","unstructured":"Lam BK, Chan V, Hendry P, et al. The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg. 2007;133:1464\u201373.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1761_CR39","doi-asserted-by":"crossref","unstructured":"Aziz A, Lawton JS, Maniar HS, Pasque MK, Damiano RJ, Jr., Moon MR. Factors affecting survival after mitral valve replacement in patients with prosthesis-patient mismatch. Ann Thorac Surg 2010;90:1202\u201310; discussion 1210\u20131.","DOI":"10.1016\/j.athoracsur.2010.05.018"},{"key":"1761_CR40","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/icvts\/ivx426","volume":"26","author":"SS Aboul-Hassan","year":"2018","unstructured":"Aboul-Hassan SS, Stankowski T, Marczak J, Cichon R. Does patient-prosthesis mismatch have a negative impact on outcomes following mitral valve replacement? Interact Cardiovasc Thorac Surg. 2018;26:1027\u201334.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"1761_CR41","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jcin.2017.10.047","volume":"11","author":"N Kamioka","year":"2018","unstructured":"Kamioka N, Corrigan F, Iturbe JM, et al. Mitral Bioprosthetic valve fracture: bailout procedure for undersized bioprosthesis during mitral valve-in-valve procedure with paravalvular leak closure. JACC Cardiovasc Interv. 2018;11:e21\u20132.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01761-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-022-01761-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-022-01761-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T23:11:49Z","timestamp":1665616309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-022-01761-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1761"],"URL":"https:\/\/doi.org\/10.1007\/s11886-022-01761-x","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"1 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Marvin H. Eng, MD, is a clinical proctor for Edwards Lifesciences and Medtronic. Amr Abbas, MD, is a consultant to Edwards Lifesciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}